Programmable Bacteria: An Emerging Therapeutic
Candice R. Gurbatri(Tempus Labs (United States)), Tal Danino(Herbert Irving Comprehensive Cancer Center), Tetsuhiro Harimoto(Columbia University)
Cited by 0
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
|Science Translational Medicine|2020|600
Engineering bacteria as interactive cancer therapies
|Science|2022|411
Probiotic-guided CAR-T cells for solid tumor targeting
|Science|2023|251
Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
|Nature Communications|2024|172